Literature DB >> 6741030

Stabilization of human albumin by caprylate and acetyltryptophanate.

M W Yu, J S Finlayson.   

Abstract

The thermal stabilization of human albumin by caprylate (CA) and acetyltryptophanate (AT) was studied by monitoring the formation of albumin polymer (defined as species larger than dimer) on the basis of its molecular size as well as its characteristic migration as alpha-globulin. Heating 5% protein solutions of purified albumin monomer, cohn fraction V, and fraction IV-4 + V at 60 degrees C in 0.1 M sodium phosphate or 145 mM sodium chloride, pH 7.0, established the following order of stabilizer effectiveness: 4 mM CA + 4 mM AT approximately 4 mM CA greater than 8 mM AT greater than or equal to 2 mM CA greater than 4 mM AT. However, albumin was more thermally stable in the chloride medium. Raising the CA concentration above 4 mM provided little additional stabilization. The D- and L-enantiomers of AT were equally effective, but 16 mM AT was needed to equal the effect of 4 mM CA. L-Tryptophanate exerted only slight stabilization, even at 32 mM; D-tryptophanate was even less effective. The albumin polymer level increased progressively with time at 60 degrees C in 2 mM CA or 4 mM AT, whereas in 4 mM CA it reached a plateau in 4-6 h. Acetone drying of albumin-rich fractions was shown to remove nearly all endogenous fatty acid, rendering the protein thermally labile unless sufficient exogenous stabilizer(s) was added. Even in the presence of 145 mM sodium chloride and 4 mM CA + 4 mM AT or 4 mM CA, the stabilizing effect of endogenous fatty acid was still detectable.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6741030     DOI: 10.1111/j.1423-0410.1984.tb01558.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  3 in total

1.  Interaction between various polymerized human albumins and hepatitis B surface antigen.

Authors:  M W Yu; J S Finlayson; J W Shih
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

2.  Removal of stabilizers from human serum albumin by adsorbents and dialysis used in blood purification.

Authors:  Stephan Harm; Claudia Schildböck; Jens Hartmann
Journal:  PLoS One       Date:  2018-01-24       Impact factor: 3.240

3.  Absence of the CXCR4 antagonist EPI-X4 from pharmaceutical human serum albumin preparations.

Authors:  Andrea Gilg; Mirja Harms; Lia-Raluca Olari; Ann-Kathrin Urbanowitz; Halvard Bonig; Jan Münch
Journal:  J Transl Med       Date:  2021-05-03       Impact factor: 8.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.